Sales 2024 * | 2.6B 208B | Sales 2025 * | 2.73B 218B | Capitalization | 1.81B 145B |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.12B | Net income 2025 * | 22M 1.76B | EV / Sales 2024 * | 1.58 x |
Net Debt 2024 * | 2.29B 183B | Net Debt 2025 * | 2.07B 166B | EV / Sales 2025 * | 1.42 x |
P/E ratio 2024 * |
117
x | P/E ratio 2025 * |
65.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.94% |
Latest transcript on Impax Laboratories Inc
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 31/12/01 |
Chintu Patel
FOU | Founder | 53 | 31/12/01 |
Director of Finance/CFO | 57 | 11-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | 11-06 |
J. Buchi
BRD | Director/Board Member | 69 | 11-06 |
Paul Meister
CHM | Chairman | 71 | 11-06 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |